<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02282670</url>
  </required_header>
  <id_info>
    <org_study_id>DA5204_GR_III</org_study_id>
    <nct_id>NCT02282670</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Efficacy and Safety of DA-5204</brief_title>
  <official_title>A Phase III Clinical Trial to Evaluate the Efficacy and Safety of DA-5204 and to Demonstrate the Non-inferiority of DA-5204 Compared With Stillen Tab. in Patients With Acute or Chronic Gastritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dong-A ST Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dong-A ST Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, active-controlled, randomized, double-blinded, paralleled group
      clinical study to evaluate the efficacy and safety of DA-5204 and to demonstrate the
      non-inferiority of DA-5204 compared with StillenÂ® tab. in patients with acute or chronic
      gastritis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>A percentage of subjects showed moderate or significant improvement of stomach erosions by the endoscopy.</measure>
    <time_frame>2 weeks</time_frame>
    <description>The definition of &quot;moderate improvement&quot; is the subjects showed score changed from 4 to 1 or from 2 to 1. And, &quot;significant improvement&quot; means the subject showed score changed from 4 to 1 or from 3 to 1.
[score 1(normal) : no erosion, score 2(mild) : 1-2 erosions, score 3(moderate) : 3-5 erosions, score 4(severe) : 6 or more erosions]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>A percentage of completely cured subject after a treatment</measure>
    <time_frame>2 weeks</time_frame>
    <description>The definition of &quot;completely cured&quot; is the subjects with no erosions, in other words, 0 erosion found at stomach by the endoscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A percentage of subjects showed morderate or significant improvement of gastric symptom rating scale.</measure>
    <time_frame>2 weeks</time_frame>
    <description>The definition of &quot;moderate improvement&quot; is the subjects showed reduction ratio of score changed from 50% to 75%. And, &quot;singnificant improvement&quot; means the subjects showed reduction ratio of score changed 75% or more. Reduction ratio of score is calculated as [1-(total score of 7 days before termination of treatment)/(total score of 7 days before treatment)].</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">434</enrollment>
  <condition>Acute Gastritis</condition>
  <condition>Chronic Gastritis</condition>
  <arm_group>
    <arm_group_label>DA-5204</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DA-5204 administered two times daily for two weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stillen tab.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stillen tab. administered three times daily for two weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DA-5204</intervention_name>
    <arm_group_label>DA-5204</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Stillen tab.</intervention_name>
    <arm_group_label>Stillen tab.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age is over 20 years old, under 75 years old, men or women

          -  Patients diagnosed with acute or chronic gastritis by gastroscopy

          -  Patients with one or more erosions found by gastroscopy

          -  Signed the informed consent forms

        Exclusion Criteria:

          -  Patients who is impossible to receive gastroscopy

          -  Patients with peptic ulcer and gastroesophageal reflux disease

          -  Patients administered with prokinetics, H2 receptor antagonists, proton pump
             inhibitors, anticholinergic drugs or non-steroid anti-inflammatory drugs prior to
             study in 2 weeks

          -  Patients with surgery related to gastroesophageal

          -  Patients with Zollinger-Ellison syndrome

          -  Patients with any kind of malignant tumor

          -  Patients administered with anti-thrombotic drugs

          -  Patients with significant cardiovascular, pulmonary, heptic, renal, hemopoietic or
             endocrine system primary disease

          -  Patients with neuropsychiatric disorder, alcoholism, or drug abuse

          -  Patients taking other investigational drugs or participating in other clinical studies
             in 4 weeks.

          -  Women either pregnant or breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dong Ho Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Myung Gyu Choi, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University, Seoul St. Mary's Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sung Joon Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kangwon National University Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sung Kuk Kim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyungbuk National University Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Geun Am Song, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pusan National Universtiy Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Poong Lyeol Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hwoon Yong Jung, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dae Hwan Kang, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pusan National University Yangsan Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yong Chan Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yonsei University, Severance Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Si Hyung Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yeungnam University Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suck Chei Choi, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wonkwang University Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gi Nam Sim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ewha Womans University Medical Center of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sang Young Seoul, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University Busan Paik Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeong Seop Moon, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University Seoul Paik Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yong Woon Shin, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inha University Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hyen Soo Kim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonnam National Universtiy Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Soo Teik Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonbuk National Universtiy Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jin Woong Cho, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Presbyterian medical center in Jeonju of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eun Kwang Choi, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jeju National Universtiy Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Soon Man Yoon, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chungbuk National University Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oh Young Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang Universtiy Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jin Seok Jang, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dong-A University Hospital of Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National Universtiy, Bundang Hospital, IRB</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2014</study_first_submitted>
  <study_first_submitted_qc>October 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2014</study_first_posted>
  <last_update_submitted>October 31, 2014</last_update_submitted>
  <last_update_submitted_qc>October 31, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastritis</mesh_term>
    <mesh_term>Gastritis, Atrophic</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>September 19, 2016</submitted>
    <returned>November 4, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

